Concord Biotech IPO vs SBFC Finance IPO

Comparision between Concord Biotech IPO and SBFC Finance IPO.

IPO Details

Concord Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while SBFC Finance IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Concord Biotech IPO	SBFC Finance IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited Jefferies India Private Limited	ICICI Securities Limited Axis Capital Limited Kotak Mahindra Capital Company Limited
Registrar	Link Intime India Private Ltd	Kfin Technologies Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Concord Biotech IPO is up to ₹1,551.00 Cr whereas the issue size of the SBFC Finance IPO is up to ₹1,025.00 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of SBFC Finance IPO is ₹57.00 per share.

	Concord Biotech IPO	SBFC Finance IPO
Face Value	₹1 per share	₹10 per share
Issue Price (Lower)	₹705.00 per share	₹54.00 per share
Issue Price (Upper)	₹741.00 per share	₹57.00 per share
Issue Price (Final)	₹741.00 per share	₹57.00 per share
Discount (Retail)
Discount (Employee)	₹70.00 per share	₹2.00 per share
Market Lot Size	20 shares	260 shares
Fresh Issue Size
Fresh Issue Size (Amount)		up to ₹600.00 Cr
OFS Issue Size	2,09,25,652 shares
OFS Issue Size (Amount)	up to ₹1,551.00 Cr	up to ₹425.00 Cr
Issue Size Total	2,09,25,652 shares
Issue Size Total (Amount)	up to ₹1,551.00 Cr	up to ₹1,025.00 Cr

IPO Timetable

Concord Biotech IPO opens on Aug 04, 2023, while SBFC Finance IPO opens on Aug 03, 2023. The closing date of Concord Biotech IPO and SBFC Finance IPO is Aug 08, 2023, and Aug 07, 2023, respectively.

	Concord Biotech IPO	SBFC Finance IPO
Anchor Bid Date	Aug 03, 2023	Aug 02, 2023
Issue Open	Aug 04, 2023	Aug 03, 2023
Issue Close	Aug 08, 2023	Aug 07, 2023
Basis Of Allotment (Tentative)	Aug 11, 2023	Aug 10, 2023
Initiation of Refunds (Tentative)	Aug 14, 2023	Aug 11, 2023
Credit of Share (Tentative)	Aug 17, 2023	Aug 14, 2023
Listing date (Tentative)	Aug 18, 2023	Aug 16, 2023
Anchor Lockin End date 1	Sep 10, 2023	Sep 09, 2023
Anchor Lockin End date 2	Nov 09, 2023	Nov 08, 2023

Financials

Concord Biotech IPO P/E ratio is 32.29, as compared to SBFC Finance IPO P/E ratio of 40.42.

Concord Biotech IPO

SBFC Finance IPO

Financial

Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	1,182.55	1,312.80	1,513.98
Revenue	630.75	736.35	888.48
Profit After Tax	234.89	174.93	240.08
Net Worth	999.37	1,103.22	1,290.00
Reserves and Surplus
Total Borrowing	86.35	60.59	31.24

Amount in ₹ Crore

SBFC Finance IPO Financial Information (Restated)
Period Ended	31 Mar 2020	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	4,207.99	4,231.19	4,515.03	5,746.44
Revenue	444.85	511.53	530.70	740.36
Profit After Tax	35.50	85.01	64.52	149.74
Net Worth	752.09	944.72	1,026.78	1,466.88
Reserves and Surplus
Total Borrowing	3,056.38	2,772.55	2,948.82	3,745.83

Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

44.08%

78.83%

Promoter Shareholding (Post-Issue)

44.08%

64.03%

P/E Ratio

32.29

40.42

Market Cap

₹7752.06 Cr.

₹6065.78 Cr.

ROE

20.06%%

9.93%%

ROCE

24.27%%

Debt/Equity

2.2

EPS

₹20.79

₹1.25

RoNW

20%%

7.97%%

Shares Offered

In the Concord Biotech IPO retail investors (RII) are offered 73,20,479 shares while in SBFC Finance IPO retail investors are offered 73,20,479 shares. Qualified institutional buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 3,56,05,261 shares in SBFC Finance IPO.

	Concord Biotech IPO	SBFC Finance IPO
Anchor Investor Reserveration	62,74,695 shares	5,34,07,893 shares
Market Maker Reserveration
QIB	41,83,130 shares	3,56,05,261 shares
NII	31,37,348 shares	2,67,03,948 shares
RII	73,20,479 shares	6,23,09,210 shares
Employee	10,000 shares	18,63,636 shares
Others
Total	1,46,50,957 shares	12,64,82,055 shares

Bids Received (Subscription)

Concord Biotech IPO subscribed 24.87x in total, whereas SBFC Finance IPO subscribed 74.06x.

	Concord Biotech IPO	SBFC Finance IPO
QIB (times)	67.67x	203.61x
NII (times)	16.99x	51.82x
Big NII (times)	19.30x	56.69x
Small NII (times)	12.37x	42.07x
RII (times)	3.78x	11.60x
Employee (times)	24.48x	6.21x
Other (times)
Total (times)	24.87x	74.06x

Compare with others

Concord Biotech IPO	SBFC Finance IPO
Aeroflex Industries IPO	Pyramid Technoplast IPO
Pyramid Technoplast IPO	India Shelter Finance IPO
India Shelter Finance IPO	Balaji Speciality Chemicals IPO
Balaji Speciality Chemicals IPO	TVS Supply Chain Solutions IPO
TVS Supply Chain Solutions IPO	Concord Biotech IPO
SBFC Finance IPO	Yatharth Hospital IPO
Yatharth Hospital IPO	Netweb Technologies India IPO
Netweb Technologies India IPO	Utkarsh Small Finance Bank IPO
Utkarsh Small Finance Bank IPO	Senco Gold IPO
Senco Gold IPO	Cyient DLM IPO

Comments

Add a public comment...